5/25/2025
Last update
5/25/2025
Reviewed By
Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.5
USERS' SCORE
Moderately Good
Based on 82 Reviews
7.5
Supplement Facts
Serving Size: 2 Tablets
Amount Per Serving
%DV
Magnesium (from 2,000 mg magnesiumlysinate glycinate chelate) (Albion®)
200 mg
48%
Top Medical Research Studies
8
Magnesium scaffold shows promising results
We investigated the clinical safety and performance of a new magnesium scaffold known as DREAMS 3G. This innovative treatment aims to match the effectiveness of drug-eluting stents in coronary interventions.
Over one year, a total of 116 patients were monitored, showing promising results with minimal lumen loss and no adverse events like cardiac death or major thrombosis. Despite a few revascularization interventions, the scaffold appears to be a viable alternative.
Overall, our findings support its potential use in heart treatments.
Over one year, a total of 116 patients were monitored, showing promising results with minimal lumen loss and no adverse events like cardiac death or major thrombosis. Despite a few revascularization interventions, the scaffold appears to be a viable alternative.
Overall, our findings support its potential use in heart treatments.
Read More
9
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
Read More
8
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Read More
Most Useful Reviews
7.5
Blood clot prevention
112 people found this helpful
Magnesium reduces the activity of substances that contribute to blood clot formation. It is crucial for maintaining heart health and should be taken by everyone for optimal cardiovascular function.
Read More
9
Migraine solution
56 people found this helpful
After suffering from debilitating migraines for twenty years, I discovered that my magnesium deficiency was a trigger. The suggested dose for migraines is 400-800 mg daily. Following years of futile treatments, I finally found my answer. Over the past ten months, I’ve only had two headaches, which were merely stress-induced. It's crucial to take it daily for effective management, allowing it to build up in my bloodstream for sustained relief.
Read More
10
Remarkable Blood Pressure reduction
53 people found this helpful
My blood pressure has improved significantly; it used to be 160/90, now it averages at 115/65. This is fantastic!
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.5
- All Researches
9
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
Read More
8
We explored whether magnesium intake could influence the risk of retinal vein occlusion (RVO), a leading cause of vision loss. Our analysis involved over 16,000 participants from a national health survey.
We discovered that sufficient magnesium intake was linked to a significant 64% reduced risk of RVO.
This finding was especially relevant for adults under 60, those with hypertension, and individuals without glaucoma. Further studies are needed to confirm magnesium's preventive benefits for RVO.
We discovered that sufficient magnesium intake was linked to a significant 64% reduced risk of RVO.
This finding was especially relevant for adults under 60, those with hypertension, and individuals without glaucoma. Further studies are needed to confirm magnesium's preventive benefits for RVO.
Read More
8
Effective clay-based hemostatic sponge
We examined a new sponge made from clay and collagen to control severe bleeding. Integrating palygorskite clay with collagen using gallic acid created a sponge that resists particle shedding and provides strong adhesion.
In our tests, this sponge demonstrated impressive results, reducing blood loss to 632 mg and achieving hemostasis in just 151 seconds, outperforming traditional gauze and even a well-known product called QuikClot.
With added antibacterial and antioxidant properties, this sponge could significantly enhance emergency bleeding management.
In our tests, this sponge demonstrated impressive results, reducing blood loss to 632 mg and achieving hemostasis in just 151 seconds, outperforming traditional gauze and even a well-known product called QuikClot.
With added antibacterial and antioxidant properties, this sponge could significantly enhance emergency bleeding management.
Read More
8
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Read More
8
Bioresorbable stents' advancements noted
We explored the evolution of bioresorbable metallic stents as alternatives to traditional stents which can lead to complications like thrombosis and inflammation.
While bioresorbable polymeric stents face challenges, materials like zinc and magnesium show promise.
Specifically, magnesium-based stents have demonstrated successful absorption within a year and low rates of complications.
Continuing research will be essential to refine these innovations for better clinical outcomes.
While bioresorbable polymeric stents face challenges, materials like zinc and magnesium show promise.
Specifically, magnesium-based stents have demonstrated successful absorption within a year and low rates of complications.
Continuing research will be essential to refine these innovations for better clinical outcomes.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 82 Reviews
7.5
- All Reviews
- Positive Reviews
- Negative Reviews
7.5
Blood clot prevention
112 people found this helpful
Magnesium reduces the activity of substances that contribute to blood clot formation. It is crucial for maintaining heart health and should be taken by everyone for optimal cardiovascular function.
Read More
9
Migraine solution
56 people found this helpful
After suffering from debilitating migraines for twenty years, I discovered that my magnesium deficiency was a trigger. The suggested dose for migraines is 400-800 mg daily. Following years of futile treatments, I finally found my answer. Over the past ten months, I’ve only had two headaches, which were merely stress-induced. It's crucial to take it daily for effective management, allowing it to build up in my bloodstream for sustained relief.
Read More
10
Remarkable Blood Pressure reduction
53 people found this helpful
My blood pressure has improved significantly; it used to be 160/90, now it averages at 115/65. This is fantastic!
Read More
7.5
Enhanced relaxation
22 people found this helpful
This magnesium chelate supplement has been excellent for my low magnesium levels. It took three weeks for me to notice improvements. My blood pressure normalised, I feel calmer, and I sleep better at night. While I currently take 10 tablets daily to enhance magnesium intake, I expect even better results over time. It effectively alleviates headaches and migraines, although consistent dosing is essential for relief. Overall, I highly recommend it alongside a balanced vitamin/mineral supplement.
Read More
9
Natural relaxation aid
18 people found this helpful
This is the best magnesium I’ve tried compared to others, including the Now brand. It effectively aids relaxation and helps maintain my blood pressure.
Read More
Frequently Asked Questions
7.5
Enhanced relaxation
22 people found this helpful
This magnesium chelate supplement has been excellent for my low magnesium levels. It took three weeks for me to notice improvements. My blood pressure normalised, I feel calmer, and I sleep better at night. While I currently take 10 tablets daily to enhance magnesium intake, I expect even better results over time. It effectively alleviates headaches and migraines, although consistent dosing is essential for relief. Overall, I highly recommend it alongside a balanced vitamin/mineral supplement.
9
Beneficial during pregnancy
3 people found this helpful
This affordable magnesium was well-suited for me during pregnancy. It improved my wellbeing and alleviated discomfort. My husband started using it to combat increased blood pressure, and within a week, his pressure normalised. I plan to get more for my parents as well.
9
Natural relaxation aid
18 people found this helpful
This is the best magnesium I’ve tried compared to others, including the Now brand. It effectively aids relaxation and helps maintain my blood pressure.
9
Migraine solution
56 people found this helpful
After suffering from debilitating migraines for twenty years, I discovered that my magnesium deficiency was a trigger. The suggested dose for migraines is 400-800 mg daily. Following years of futile treatments, I finally found my answer. Over the past ten months, I’ve only had two headaches, which were merely stress-induced. It's crucial to take it daily for effective management, allowing it to build up in my bloodstream for sustained relief.
10
Remarkable Blood Pressure reduction
53 people found this helpful
My blood pressure has improved significantly; it used to be 160/90, now it averages at 115/65. This is fantastic!
9
Normal blood pressure
7 people found this helpful
I started my husband on this for his high blood pressure. He now only takes hawthorn once daily, and his blood pressure has normalised from 189/120.
7.5
Reduced heart skips
1 people found this helpful
This product has noticeably helped reduce the frequency of skipped heartbeats, which were quite distressing. It has alleviated the heaviness and constriction in my chest and has mildly lowered my borderline high blood pressure.
7.5
Blood clot prevention
112 people found this helpful
Magnesium reduces the activity of substances that contribute to blood clot formation. It is crucial for maintaining heart health and should be taken by everyone for optimal cardiovascular function.
9
Cramp relief
1 people found this helpful
Living under constant stress prompted me to take magnesium after my doctor advised it for frequent migraines. I had tried various treatments with limited success. This supplement has been a godsend, as I experience far fewer migraines now. I combine it with vitamin B6, and it doesn't cause heartburn. Magnesium supports energy production, thus reducing fatigue, particularly important for anyone in a high-stress urban environment. It aids relaxation and helps me tackle the demands of daily life better.
9
Blood pressure reduction
1 people found this helpful
Helped to take 10 points off my blood pressure. I tried this product after reading about it in the IHerb reviews. The tablets are large, but manageable with liquid. The manufacturer recommends 2 tablets twice daily. I have been using it for 2 months and got excellent results. I have a thyroid condition (hypo), and taking magnesium has reduced my blood pressure by about 10 to 12 points on average. There has been no downside thus far, and I tolerate it well. I reordered 2 larger bottles for better value. Great product at a really good price!
8
Improved sleep quality
1 people found this helpful
Wonderful, I can't do without it due to terrible insomnia and a sudden rise in blood pressure. I take two pills before bed, and it makes my sleep somewhat better. Although it’s not a sleeping pill, it helps enhance sleep quality, promoting deeper rest. Thankfully, it also controls my blood pressure, which I have noticed and greatly benefited from. If you find this evaluation helpful, please like and thank you.
8
We aimed to examine how bioresorbable magnesium scaffolds influence blood clotting. Using a cutting-edge stent flow chamber system, we compared the thrombogenicity of various stents, including the Magmaris magnesium scaffold and a prototype called DREAMS 3G.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
Our findings indicated that the Magmaris scaffold exhibited significantly lower thrombogenicity than traditional stainless steel stents. Impressively, the DREAMS 3G prototype demonstrated even further reductions in clotting risks, suggesting it could enhance patient safety.
This study highlights the potential of magnesium-based scaffolds in improving cardiovascular treatments.
8
MAGT1 deficiency increases thrombosis risk
We studied how a lack of magnesium transporter 1 (MAGT1) impacts blood clot formation and the risk of stroke. Using various laboratory and animal models, we observed that MAGT1 deficiency leads to enhanced platelet activity and quicker clotting. This deficiency resulted in faster artery blockage and severe brain damage during strokes. Interestingly, restoring magnesium levels or blocking certain channels helped normalize platelet behavior. Overall, we found that MAGT1's function is crucial for vascular health, indicating its deficiency could elevate risks for thrombosis and ischemic stroke.
7
We looked into how magnesium levels impact blood clotting during sepsis. In our study of ICU patients, we found that those with low magnesium (hypomagnesemia) showed a higher likelihood of having activated coagulation and suppressed fibrinolysis.
Notably, hypomagnesemia was linked to coagulopathy, specifically disseminated intravascular coagulation (DIC). This suggests that boosting magnesium levels could be a promising way to address blood clotting issues in septic patients.
Notably, hypomagnesemia was linked to coagulopathy, specifically disseminated intravascular coagulation (DIC). This suggests that boosting magnesium levels could be a promising way to address blood clotting issues in septic patients.
9
We investigated the effects of magnesium oxide nanoparticles, created using fruit extract, on blood clotting and oxidative stress. Our experiments showed that these nanoparticles significantly extended clotting time, indicating an anticoagulant effect. They also effectively reduced damage to red blood cells and various tissues in laboratory tests, helping to restore their function. Importantly, we found these nanoparticles non-toxic, suggesting they could be a promising treatment option for oxidative stress-related conditions without adverse side effects. However, further research is needed to fully understand their potential in clinical applications.
References
- Kim J, Kim M, Lee CS, Choi EY. Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis. Nutrients. 2025;17. 10.3390/nu17071285
- Guo X, Zeng X, He Y, Zhang X, Shi W, et al. An Antibacterial, Antioxidant Adherent Sponge Constructed for Control of Arterial Bleeding Via Gallic Acid-Mediated Robust Assembly of Fibrous Clay in Collagen. ACS Appl Mater Interfaces. 2025;17:16489. 10.1021/acsami.4c19209
- Müller M, Ludwig L, Englert H, Riedl KA, Müller MC, et al. A novel stent flow chamber system demonstrates reduced thrombogenicity of bioresorbable magnesium scaffolds. Sci Rep. 2024;14:26691. 10.1038/s41598-024-77266-0
- Zhang J, Chen Z, Rao L, He Y. Coronary bioresorbable metallic stents: Advancements and future perspectives. J Cardiol. 2025;85:69. 10.1016/j.jjcc.2024.08.003
- Włodarczak A, Rola P, Włodarczak S, Szudrowicz M, Giniewicz K, et al. Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions. J Pers Med. 2024;14. 10.3390/jpm14050540
- Galli S, Troiano S, Palloshi A, Rapetto C, Pisano F, et al. Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry. Cardiovasc Revasc Med. 2023;57:53. 10.1016/j.carrev.2023.06.022
- Włodarczak A, Rola P, Barycki M, Furtan Ł, Łanocha M, et al. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds - magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort. Diab Vasc Dis Res. 2023;20:14791641231188705. 10.1177/14791641231188705
- Gotru SK, Mammadova-Bach E, Sogkas G, Schuhmann MK, Schmitt K, et al. MAGT1 Deficiency Dysregulates Platelet Cation Homeostasis and Accelerates Arterial Thrombosis and Ischemic Stroke in Mice. Arterioscler Thromb Vasc Biol. 2023;43:1494. 10.1161/ATVBAHA.122.318115
- Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, et al. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. EuroIntervention. 2023;19:e414. 10.4244/EIJ-D-23-00326
- Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Starmer G, et al. One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry. EuroIntervention. 2023;19:232. 10.4244/EIJ-D-22-01069
- Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, et al. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study. EClinicalMedicine. 2023;59:101940. 10.1016/j.eclinm.2023.101940
- Pompei G, Campo G, Ruggiero R, Maffeo D, Sgura F, et al. Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study. Int J Cardiol. 2023;383:1. 10.1016/j.ijcard.2023.04.029
- Fedele G, Castiglioni S, Maier JAM, Locatelli L. The Effects of Sirolimus and Magnesium on Primary Human Coronary Endothelial Cells: An In Vitro Study. Int J Mol Sci. 2023;24. 10.3390/ijms24032930
- Tonai K, Katayama S, Koyama K, Sata N, Tomioka Y, et al. Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study. BMC Anesthesiol. 2022;22:359. 10.1186/s12871-022-01903-2
- Seguchi M, Aytekin A, Lenz T, Nicol P, Alvarez-Covarrubias HA, et al. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation. J Cardiol. 2023;81:179. 10.1016/j.jjcc.2022.09.003
- Venkatappa MM, Udagani C, Hanumegowda SM, Pramod SN, Venkataramaiah S, et al. Effect of Biofunctional Green Synthesized MgO-Nanoparticles on Oxidative-Stress-Induced Tissue Damage and Thrombosis. Molecules. 2022;27. 10.3390/molecules27165162
